Source: Biospectrum Asia

biolabs: 360biolabs to join R&D efforts to combat COVID-19

360biolabs to join R&D efforts to combat coronavirus disease

Read full article »

biolabs's Competitors | biolabs's News | biolabs's Financials

Followers on Owler

329

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Co-Founder

Melinda Pryor

CEO Approval Rating

82/100

360biolabs is an Australia-based contract service organization that provides services such as virology and pharmacokinetics for the development of therapeutics and vaccines.